FindTrial
Sign In

A clinical trial to study the benefits of yoga therapy in Prediabetic and Diabetic patients.

Association of sympathovagal imbalance with cardiovascular and metabolic dysfunction and effects of yoga therapy in the alleviation of these dysfunctions in prediabetes and diabetes - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2014/07/004754
Enrollment
310
Registered
2014-07-23
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Diabetes Mellitus

Interventions

Intervention1: Yoga therapy(For 3 months): The yoga therapy group patients also receive the STANDARD MEDICAL THERAPY and Yoga therapy as Add â?? On therapy in group III & V. The patients will undergo
SURYANAMASKARA (3 MIN):3 Rounds with Breathing
ASANA (15 Min):Padahastasana, Konasana, Vakrasana, Ardhamatseyndrasana, Paschimottanasana, Shalabhasana, Dhanurasana, pavanamuktasana, Ardha Halasana, Sarala Matsyasana
PRANAYAMA (10 Min):Nadi Shodhana Pranayama(9 rounds), Bhramari Pranayama (9 rounds) ,Chandra Nadi Pranayama (9 rounds)
MEDITATION (2 Min):A kara (3 rounds ), U kara (3 rounds ), M kara (3 rounds), A-U-M kara (3 rounds )
RELAXATION (10 min):Shavasana, Yoga Nidra & A-U-M Chanting, Total Duration of Practice â?? 45 min. Duration of therapy- 3 months Control Intervention1: Standard medical therapy for diabetes and life

Sponsors

JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION RESEARCH
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Group I: Control group (Normal healthy subjects). Group II & III: Prediabetes (FPG: 100-125 mg/dl) Group IV&V: Diabetes (FPG: >=126 mg/dl)

Exclusion criteria

Exclusion criteria: Known cases of hypertension, heart disease, endocrinal diseases, history of smoking, kyphoscoliosis, Neuromuscular diseases Drugs known to influence glycemic status like steroids.

Design outcomes

Primary

MeasureTime frame
1.Role of yoga in preventing the cardiovascular and metabolic dysfunctions in prediabetes and diabetes. 2.Cardiac function assessed by Echocardiography 3.Oxidative stress: Total antioxidant status,Plasma MDA. Biomarkers: Insulin,FBS Inflammation â?? hs CRP,TNFα, γ-interferon, IgE, IL-6, leptin, adiponectin. Oxidative stress marker â?? Plasma MDA Endothelial markers: sICAM -1,Soluble E-selectin, Angiotensin-II, NO comborbities: Renal and creatinine, Lipid profile Timepoint: 0 days, After 12 weeks of Yoga Therapy / LSM—

Secondary

MeasureTime frame
1.Nature and magnitude of Sympathovagal imbalance (SVI) assessed by AFT and HRV. 2.Link of sympathovagal imbalance to cardiovascular and metabolic dysfunctions in prediabetes and diabetes 3.QOL, IDRS (Indian Diabetes Risk Score), Timepoint: 0 days, After 12 weeks of Yoga Therapy / LSM—

Countries

India

Contacts

Public ContactG Shravya Keerthi

JIPMER

drpravatipal@gmail.com09360682406

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026